Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors

By afschroeder • November 20, 2025

Blauvelt A, Strober BE, Eakin GS, McCormick Howard L, Langan C, van de Kerkhof PCM, Puig L, Lebwohl MG, Romiti R, Armstrong AW, Choon SE, Ramessur R, Gelfand JM, Merola JF, Winthrop KL, Torres T. Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors. J Am Acad Dermatol. 2025 Nov 17:S0190-9622(25)03232-3. doi: 10.1016/j.jaad.2025.11.033. Epub ahead of print. PMID: 41260526.

Tags: Dermatology, Publications

A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified by immune checkpoint inhibition

Johnsen NA, Carlisle R, Baghoomian W, Pierce JL, Nguyen MO. A novel case of acute localized and generalized exanthematous pustulosis following IL-2 analogue injection amplified[...]

A rare case of dystrophic calcinosis cutis in an infant

Yan MJ, Shen A, Galamgam J, Hogeling M, Cheng C. A rare case of dystrophic calcinosis cutis in an infant. JAAD Case Rep. 2025 Oct[...]

An atypical case of pemphigus herpetiformis with erythroderma

Jeong C, Chou PP, Dong E, Shen A, McKenzie S, Lane F, Smart C, Kang Y, Kasperkiewicz M, Armstrong AW. An atypical case of pemphigus[...]